Dr. Martens Management

Management criteria checks 4/4

Dr. Martens' CEO is Kenny Wilson, appointed in Jul 2018, has a tenure of 5.75 years. total yearly compensation is £773.00K, comprised of 93.3% salary and 6.7% bonuses, including company stock and options. directly owns 1.2% of the company’s shares, worth £8.38M. The average tenure of the management team and the board of directors is 3.6 years and 3.3 years respectively.

Key information

Kenny Wilson

Chief executive officer

UK£773.0k

Total compensation

CEO salary percentage93.3%
CEO tenure5.8yrs
CEO ownership1.2%
Management average tenure3.6yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Mar 27
The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Dr. Martens (LON:DOCS) Has A Somewhat Strained Balance Sheet

Mar 06
Dr. Martens (LON:DOCS) Has A Somewhat Strained Balance Sheet

Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 57% Above Its Share Price

Feb 08
Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 57% Above Its Share Price

Dr. Martens plc's (LON:DOCS) Business And Shares Still Trailing The Market

Jan 21
Dr. Martens plc's (LON:DOCS) Business And Shares Still Trailing The Market

Dr. Martens' (LON:DOCS) Dividend Will Be £0.0156

Jan 03
Dr. Martens' (LON:DOCS) Dividend Will Be £0.0156

Dr. Martens (LON:DOCS) Will Pay A Dividend Of £0.0156

Dec 13
Dr. Martens (LON:DOCS) Will Pay A Dividend Of £0.0156

Dr. Martens (LON:DOCS) Is Very Good At Capital Allocation

Oct 12
Dr. Martens (LON:DOCS) Is Very Good At Capital Allocation

Calculating The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Sep 13
Calculating The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Returns on Capital Paint A Bright Future For Dr. Martens (LON:DOCS)

Jul 12
Returns on Capital Paint A Bright Future For Dr. Martens (LON:DOCS)

A Look At The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Jun 02
A Look At The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Dr. Martens (LON:DOCS) Is Investing Its Capital With Increasing Efficiency

Feb 25
Dr. Martens (LON:DOCS) Is Investing Its Capital With Increasing Efficiency

Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 34% Undervaluation?

Dec 17
Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 34% Undervaluation?

The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Oct 02
The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Dr. Martens (LON:DOCS) Knows How To Allocate Capital Effectively

Jul 04
Dr. Martens (LON:DOCS) Knows How To Allocate Capital Effectively

Why Investors Shouldn't Be Surprised By Dr. Martens plc's (LON:DOCS) 26% Share Price Surge

Jun 16
Why Investors Shouldn't Be Surprised By Dr. Martens plc's (LON:DOCS) 26% Share Price Surge

Are Investors Undervaluing Dr. Martens plc (LON:DOCS) By 27%?

Mar 02
Are Investors Undervaluing Dr. Martens plc (LON:DOCS) By 27%?

Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 19% Below Its Share Price

Dec 01
Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 19% Below Its Share Price

Are Dr. Martens plc (LON:DOCS) Investors Paying Above The Intrinsic Value?

Aug 24
Are Dr. Martens plc (LON:DOCS) Investors Paying Above The Intrinsic Value?

Investors Can Find Comfort In Dr. Martens' (LON:DOCS) Earnings Quality

Jun 24
Investors Can Find Comfort In Dr. Martens' (LON:DOCS) Earnings Quality

Does This Valuation Of Dr. Martens plc (LON:DOCS) Imply Investors Are Overpaying?

Apr 29
Does This Valuation Of Dr. Martens plc (LON:DOCS) Imply Investors Are Overpaying?

CEO Compensation Analysis

How has Kenny Wilson's remuneration changed compared to Dr. Martens's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

UK£103m

Jun 30 2023n/an/a

UK£116m

Mar 31 2023UK£773kUK£721k

UK£129m

Dec 31 2022n/an/a

UK£153m

Sep 30 2022n/an/a

UK£177m

Jun 30 2022n/an/a

UK£179m

Mar 31 2022UK£2mUK£700k

UK£181m

Dec 31 2021n/an/a

UK£118m

Sep 30 2021n/an/a

UK£54m

Jun 30 2021n/an/a

UK£44m

Mar 31 2021UK£815kUK£118k

UK£35m

Compensation vs Market: Kenny's total compensation ($USD966.07K) is about average for companies of similar size in the UK market ($USD1.34M).

Compensation vs Earnings: Kenny's compensation has been consistent with company performance over the past year.


CEO

Kenny Wilson (57 yo)

5.8yrs

Tenure

UK£773,000

Compensation

Mr. Kenneth Wilson, also known as Kenny, is Chief Executive Officer at Dr. Martens Limited and Dr. Martens plc since July 2018 and serves as its Director since January 5, 2021. He joined Dr. Martens Limite...


Leadership Team

NamePositionTenureCompensationOwnership
Kenneth Wilson
CEO & Director5.8yrsUK£773.00k1.2%
£ 8.2m
Jon Mortimore
CFO & Director8yrsUK£503.00k0.66%
£ 4.6m
Onyeije Nwokorie
Chief Brand Officerless than a yearUK£67.00k0.00056%
£ 3.8k
Geert Peeters
Chief Operating Officer5.8yrsno datano data
Ronald Garricks
Chief Information Officer4yrsno datano data
Meg Johnson
Chief Marketing Officer2yrsno datano data
Emily Reichwald
Chief People & Sustainability Officer and Company Secretary3.3yrsno datano data
Sean O'Neill
Chief Digital Officer6yrsno datano data
Derek Chan
President of APAC4.6yrsno datano data
Adam Meek
Chief Product Officer2.3yrsno datano data
Jennifer Somer
President of Americas2.4yrsno datano data
Mike Stopforth
President of EMEAless than a yearno datano data

3.6yrs

Average Tenure

56yo

Average Age

Experienced Management: DOCS's management team is considered experienced (3.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kenneth Wilson
CEO & Director3.3yrsUK£773.00k1.2%
£ 8.2m
Jon Mortimore
CFO & Director3.5yrsUK£503.00k0.66%
£ 4.6m
Andrew Harrison
Independent Non-Executive Directorless than a yearno data0.0019%
£ 13.1k
Ian Rogers
Independent Non-Executive Director3.3yrsUK£67.00k0.0021%
£ 14.5k
Robyn Perriss
Independent Non-Executive Director3.3yrsUK£94.00k0.010%
£ 70.9k
Tara Alhadeff
Representative Non-Independent Non-Executive Director3.3yrsno datano data
Lynne Weedall
Senior Independent Non-Executive Director3.3yrsUK£99.00k0.0022%
£ 15.0k
Paul Mason
Chair of the Board8.6yrsUK£335.00k0.82%
£ 5.6m

3.3yrs

Average Tenure

56yo

Average Age

Experienced Board: DOCS's board of directors are considered experienced (3.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.